Search Results - "Karabina, S P"

Lack of effect of acute repaglinide administration on postprandial lipaemia in patients with type 2 diabetes mellitus by Tentolouris, N, Kolia, M, Tselepis, A D, Perea, D, Kitsou, E, Kyriaki, D, Tambaki, A P, Karabina, S P, Sala, C, Fragoulopoulos, E, Katsilambros, N

“…The effect of acute repaglinide administration (2 mg) on postprandial glycaemia and lipaemia has been examined in 20 subjects with type 2 diabetes mellitus…”
Get more information

Identification of IgG1 isotype phosphorylcholine antibodies for the treatment of inflammatory cardiovascular diseases by Vries, M. R., Ewing, M. M., Jong, R. C. M., MacArthur, M. R., Karper, J. C., Peters, E. A. B., Nordzell, M., Karabina, S. A. P., Sexton, D., Dahlbom, I., Bergman, A., Mitchell, J. R., Frostegård, J., Kuiper, J., Ninio, E., Jukema, J. W., Pettersson, K., Quax, P. H. A.

“…Background Phosphorylcholine (PC) is an important pro‐inflammatory damage‐associated molecular pattern. Previous data have shown that natural IgM anti‐PC…”
Get full text

Increased activity of platelet-activating factor acetylhydrolase in low-density lipoprotein subfractions induces enhanced lysophosphatidylcholine production during oxidation in patients with heterozygous familial hypercholesterolaemia by KARABINA, S.-A. P., ELISAF, M., BAIRAKTARI, E., TZALLAS, C., SIAMOPOULOS, K. C., TSELEPIS, A. D.

“…Patients with heterozygous familial hypercholesterolaemia (FH) have elevated plasma concentrations of low‐density lipoprotein (LDL) and develop premature…”
Get full text

Glibenclamide improves postprandial hypertriglyceridaemia in Type 2 diabetic patients by reducing chylomicrons but not the very low-density lipoprotein subfraction levels by Skrapari, I., Perrea, D., Ioannidis, I., Karabina, S.-A. P., Elisaf, M., Tselepis, A. D., Karagiannacos, P., Katsilambros, N.

“…Aim  There are scarce data dealing with the degree of postprandial lipaemia after sulphonylurea administration. The aim of this study was to examine the effect…”
Get full text

Platelet-activating factor formation during oxidative modification of low-density lipoprotein when PAF-acetylhydrolase has been inactivated by Liapikos, T A, Antonopoulou, S, Karabina, S P, Tsoukatos, D C, Demopoulos, C A, Tselepis, A D

“…A PAF aggregating activity corresponding to 427 +/- 91, 668 +/- 111 and 1319 +/- 217 pg/mg protein was detected when LDL was preincubated at pH 3.5 or with 4…”
Get more information

PAF-Degrading Acetylhydrolase Is Preferentially Associated With Dense LDL and VHDL-1 in Human Plasma: Catalytic Characteristics and Relation to the Monocyte-Derived Enzyme by Tselepis, Alexandros D, Dentan, Christine, Karabina, Sonia-Athena P, Chapman, M. John, Ninio, Ewa

“…In human plasma, platelet activating factor (PAF)-degrading acetylhydrolase (acetylhydrolase) is principally transported in association with LDLs and HDLs;…”
Get full text

PAF-acetylhydrolase activity on Lp(a) before and during Cu2+-induced oxidative modification in vitro by KARABINA, S.-A. P, ELISAF, M. C, GOUDEVENOS, J, SIAMOPOULOS, K. C, SIDERIS, D, TSELEPIS, A. D

Get full text

Plasma and Lp(a)-associated PAF-acetylhydrolase activity in uremic patients undergoing different dialysis procedures by Milionis, Haralampos J., Elisaf, Moses S., Karabina, Sonia-Athena P., Bairaktari, Eleni, Tselepis, Alexandros D., Siamopoulos, Kostas C.

“…Plasma and Lp(a)-associated PAF-acetylhydrolase activity in uremic patients undergoing different dialysis procedures. Platelet-activating factor (PAF) is a…”
Get full text

PAF-acetylhydrolase activity in familial hypercholesterolaemia by A D Tselepis: S-A P Karabina, Elisaf, M

Get full text

Increased platelet reactivity to the aggregatory effect of platelet activating factor, in vitro, in patients with heterozygous familial hypercholesterolaemia by Elisaf, M., Karabina, S-A. P., Bairaktari, E., Goudevenos, J. A., Siamopoulos, K. C., Tselepis, A. D.

Get full text

Increased platelet reactivity to the aggregatory effect of platelet activating factor, in vitro, in patients with heterozygous familial hypercholesterolaemia by Elisaf, M., Karabina, S-A. P., Bairaktari, E., Goudevenos, J. A., Siamopoulos, K. C., Tselepis, A. D.

“…Patients with familial hypercholesterolacmia (FH) present with high plasma total- and low density lipoprotein (LDL)-cholesterol levels and develop premature…”
Get full text

Distribution of PAF-acetylhydrolase activity in human plasma low-density lipoprotein subfractions by Karabina, S A, Liapikos, T A, Grekas, G, Goudevenos, J, Tselepis, A D

“…The distribution of PAF-acetylhydrolase (PAF-AH) activity in 3 LDL subfractions prepared by density gradient ultracentrifugation as well as the rate of…”
Get more information

Association of the inflammatory state in active juvenile rheumatoid arthritis with hypo–high‐density lipoproteinemia and reduced lipoprotein‐associated platelet‐activating factor acetylhydrolase activity by Tselepis, Alexandros D., Elisaf, Moses, Besis, Sotiris, Karabina, Sonia‐Athena P., Chapman, M. John, Siamopoulou, Antigoni

“…Objective To investigate the relationship between the quantitative and qualitative abnormalities of apolipoprotein B (Apo B)– and Apo A‐I–containing…”
Get full text